Rapidly progressive glomerulonephritis (RPGN) is mainly caused by anti-glomerular basement membrane (GBM) antibody-mediated glomerulonephritis, immune-complex or anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides and leads to rapid loss of renal function. Detection of ANCA and autoantibodies (autoAbs) to GBM and dsDNA enables early diagnosis and appropriate treatment of RPGN aiding in preventing end-stage renal disease.
Introduction
Rapidly progressive glomerulonephritis (RPGN) is a kidney syndrome clinically characterized by rapid decline of renal function, microscopic hematuria, mild (or non-nephrotic) proteinuria, and active urinary sediment. In patients with RPGN, the glomerular filtration rate decreases over a short period of time ranging in general from a few days to 3 months. [1] Light and electron microscopy analysis reveals glomerular crescent formation as the main histopathological finding in RPGN. [2, 3] Specific autoantibody (autoAb) testing is an integral part of the serological diagnosis of RPGN and enables appropriate treatment to avoid progression to end-stage renal disease. [4, 5] From a pathological point of view taking into account the presence of autoAbs, RPGN can be stratified into 3 major groups: anti-glomerular basement membrane (GBM) autoAb disease (type I), immune complex disease (type II), and pauci-immune disease (type III). [6, 7] Of note, a proper classification is difficult and many RPGN cases remain idiopathic.
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autoAb RPGN with pulmonary hemorrhage is named Goodpasture syndrome (GPS). RPGN patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are classified as type III or pauci-immune because immune deposits are absent or scanty. Type III RPGN accounts for more than 50% of all RPGNs, especially in older ages. Of note, roughly 10% to 30% of patients with anti-GBM autoAb positivity demonstrate ANCA additionally, indicating a more progressive disease. [4, [8] [9] [10] [11] Around 30% to 40% of patients suffering from RPGN have immune-complex disease due to the presence of systemic autoimmune rheumatic disease in particular systemic lupus erythematosus (SLE). Thus, patients suffering from SLE should be checked for renal involvement, because early detection and following appropriate treatment improves the renal outcome. Furthermore, 5% to 25% of patients with immune complex glomerulonephritis show ANCA positivity. [12] [13] [14] [15] Approximately 50% of RPGN patients suffer from pauciimmune disease whereas 80% to 90% of them have elevated ANCA levels. Of note, patients suffering from AAV, particularly those with progressive granulomatosis with polyangiitis (GPA) show renal involvement in most cases (70-77%). [4, [16] [17] [18] Moreover, almost all patients suffering from other AAV like microscopic polyangiitis (MPA) show renal involvement. [4, [19] [20] [21] Patients with RPGN alone or those with additional pulmonary hemorrhage require immediate diagnosis and treatment due to the life-threatening prognosis. [22] Since clinical symptoms do not allow an appropriate differential diagnosis, fast analysis of above-mentioned autoAbs plays a pivotal role. For adequate ANCA testing, as a fact, the international consensus statement requires indirect immunofluorescence (IIF) on ethanol-fixed human neutrophils (ethN) confirmed by specific immunoassays for autoAbs to proteinase 3 (PR3-ANCA) and myeloperoxidase (MPO-ANCA). [18, [23] [24] [25] [26] All in all, up to 5 different tests with varying assay techniques should be performed to achieve a complete serological workup of patients with RPGN. Thus, a multiplex autoAb analysis combining these different techniques should be the method of choice. [27] To date, only the CytoBead technology enables such multiplex quantitative autoAb testing by digital IIF and automated IIF pattern interpretation. [28] [29] [30] Consequently, a multiplex CytoBead assay was developed to determine ANCA on neutrophils, MPO-ANCA, PR3-ANCA, and autoAbs to GBM (anti-GBM) and dsDNA (anti-dsDNA) simultaneously in patients and controls. Findings were compared with classical testing by single assays.
Methods

Patients and controls
In total, 287 patients and controls, including 40 patients suffering from GPA, 48 from MPA, 2 from eosinophilic GPA (EGPA), 42 from SLE, 43 from GPS, 57 from infectious diseases (INF), and 55 healthy subjects (HS), were included into the study (Table 1) . Specific laboratory tests for PR3-and MPO-ANCA as well as anti-GBM autoAb determination were performed in the Center of San Carlo Borromeo Hospital (Milan/Italy), where the patients were diagnosed and followed-up. Further, renal biopsies were performed on all GPS patients. Anti-dsDNA analysis was performed in Germany, Brandenburg-Technical University Cottbus-Senftenberg.
The diagnosis of clinical entities has been performed according to specific classification criteria. [ 
Detection of ANCA by IIF
The detection of ANCA (ethanol and formalin fixed) was performed by using a commercially available assay according to the instructions of the manufacturer.
Multiparametric autoAb detection with CytoBead technology
ANCA on ethN, MPO-ANCA, PR3-ANCA, and autoAbs to GMB and dsDNA were determined simultaneously by the CytoBead RPGN assay employing ethN from freshly donated human blood along with PR3 (human native), GBM antigen (human recombinant; type IV collagen a 3 chain, [32] [33] [34] MPO (human native), and dsDNA (salmon native) covalently linked to fluorescent microbeads of 9 and 15 mm (PolyAn, Berlin, Germany; excitation 610 nm/ emission 690 nm) as autoantigenic targets on glass slides with compartmented wells (Fig. 1) . [35] Fixation of neutrophils and immobilization of autoantigen-coated fluorescent beads was performed as described elsewhere. [30] A serum dilution of 1/20 was incubated 30 min at room temperature (RT). After washing, secondary antihuman IgG conjugated to AlexaFluor488 in combination with 40,6-diami- ANCA = anti-neutrophil cytoplasmic antibody, EBV = Epstein-Barr virus, F = female, GBM = glomerular basement membrane, HBV = hepatitis B virus, HCV = hepatitis C virus, IQR = interquartile range, M = male.
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dino-2-phenylindole was added and incubated for 30 min at RT, followed by a second washing step. Subsequently, slides were mounted either for automated evaluation with the IIF interpretation system AKLIDES (Medipan, Berlin, Germany) or manual analysis using a standard fluorescence microscope with green fluorescence channel (Carl Zeiss, Jena, Germany) as described elsewhere. [36] [37] [38] [39] [40] Fluorescence patterns of ethN were evaluated according to the international guidelines by AR. [25, 26] The final automated read-out was expressed in international units per mL (IU/mL) for PR3-ANCA, MPO-ANCA, and antidsDNA antibodies calibrated against the international reference sera of the Centers for Disease Control and Prevention (Serum 16 and 15, Atlanta, GA) and Wo/80, respectively. Furthermore, anti-GBM levels were determined in units per mL (U/mL) in accordance with internal standard material. All digital IIF images were captured and stored in lossless compressed tagged image file (TIF) format as reported earlier. Automated pattern recognition of ANCA IIF images was conducted as described elsewhere (Fig. 2) . [30, 37, 38] 
Analysis of coefficient of variation
Coefficient of variation (CV) was analyzed by using in-house reference sera. Each reference serum was diluted 3 times in order to get high, moderate, and low antibody concentrations.
Intra-assay CV was determined by 8 measurements for each serum while inter-assay CV was assessed by analyzing 8 determinations for each serum on 5 different days in accordance with the clinical and laboratory standards institute protocol EP15-A2. Microbead and ethN fluorescence analysis for the determination of median fluorescence intensity (MFI) was performed using AKLIDES.
Statistical analysis
The statistical analysis was performed by using MedCalc software (Version 12.4.0; MedCalc, Mariakerke, Belgium). Kruskal-Wallis test was used to compare unpaired cohorts. P values < 0.05 were considered statistically significant. Specific cut-off data were determined using receiver operating characteristic (ROC) curve analysis. 
Results
Analysis of assay parameters
The cut-off determination of each parameter analyzed by the CytoBead RPGN was performed by ROC curve analysis employing patients with GPA, MPA, GPS, and SLE as disease groups for PR3-ANCA, MPO-ANCA, anti-GBM, and antidsDNA, respectively, and disease controls as well as HS as negative groups. Cut-offs were determined to match at least 95.0% specificity and revealed for PR3-ANCA, MPO-ANCA, anti-GBM, and anti-dsDNA values of 5 IU/mL, 5 IU/mL, 7 U/mL, and 10 IU/mL, respectively (Fig. 3) . For ANCA testing by IIF pattern analysis on ethN, 70 MFI was used as cut-off as determined in an earlier study. [30] Coefficients of variation (CVs) were determined using intraand inter-assay datasets as described in "Methods" section. Intraand inter-assay CVs of specific autoAb testing to PR3-ANCA, MPO-ANCA, GBM, and dsDNA showed values <15.0% which is in line with food and drug administration criteria Q2B (Table 2) . Furthermore, intra-assay CVs of neutrophil cytoplasmic, perinuclear, and nuclear fluorescence staining patterns were also below 15.0% whereas corresponding interassay CVs exceeded 20.0% for 2/9 serum samples but were <23.0% altogether ( Table 2) .
ANCA and specific autoAb analysis by CytoBead RPGN
In total, 287 serum samples (Table 1) were analyzed for the presence of ANCA on ethN, PR3-ANCA, MPO-ANCA, anti-GBM, and antidsDNA by CytoBead technology. All 5 parameter levels demonstrated significant differences in the patient and control cohorts tested (Kruskal-Wallis test, P < 0.005, respectively; Fig. 4) .
IIF testing on ethN by CytoBead RPGN revealed prevalences between 77.1% and 100.0% in patients with SLE, GPA, MPA, and EGPA (Table 3 ). In contrast, HS and INF demonstrated prevalences of 0.0% and 1.7% only, respectively. Interestingly, The automated IIF interpretation system AKLIDES classifies cytoplasmic, perinuclear, nuclear, unrecognized, and negative fluorescence ANCA on ethanolfixed neutrophils according to international guidelines [22, 36, 37, 45] . Table 2 Intra-and inter-assay variation of (A) ANCA and (B) PR3-ANCA, MPO-ANCA, anti-GBM, and anti-dsDNA autoantibodies (autoAb) by CytoBead RPGN. ANCA = anti-neutrophil cytoplasmic antibody, CV = coefficient of variation, GBM = glomerular basement membrane, MPO = myeloperoxidase, PR3 = proteinase 3, RPGN = rapidly progressive glomerulonephritis.
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14/43 (32.6%) patients with GPS showed ANCA reactivity, of which 10 were confirmed by specific autoAb testing. Specific autoAb testing by CytoBead RPGN demonstrated prevalences of 85.0%, 77.1%, 88.4%, and 83.3% for PR3-ANCA, MPO-ANCA, anti-GBM, and anti-dsDNA in patients with GPA, MPA, GPS, and SLE, respectively (Table 3) . In contrast, HS showed prevalences between 0.0% and 5.4% and INF between 0.0% and 3.5% regarding these specific autoAbs.
Comparison of classical ANCA analysis with CytoBead RPGN testing
The performance of the multiplex CytoBead RPGN was further evaluated by comparison with classical ANCA testing by IIF and specific autoAb determination by solid-phase immunoassays. Consequently, 287 serum samples were analyzed with CytoBead RPGN and with classical tests employing IIF with ethanol and formalin-fixed neutrophils as well as specific ELISA (Table 4) . Inter-rater agreement showed very good agreement for anti-GBM autoAb, PR3-ANCA, and MPO-ANCA and fair agreement for anti-dsDNA autoAbs ( Table 4) .
As a fact, comparison of anti-dsDNA autoAb testing revealed 52/287 (18.1%) discrepant results. Thus, whereas anti-GBM autoAb, PR3-ANCA, and MPO-ANCA comparative analysis of both methods did not reveal significant differences (McNemar test, P > 0.05, respectively), testing of anti-dsDNA autoAb did (difference 12.54%, 95% confidence interval: 7.94-15.62, P < Figure 4 . Detection of autoantibodies (autoAb) to dsDNA, glomerular basement membrane (GBM), myeloperoxidase (MPO), and proteinase 3 (PR3)-antineutrophil cytoplasmic antibody (ANCA) by CytoBead RPGN. Indirect immunofluorescence findings were interpreted on the automated interpretation system AKLIDES. EGPA = eosinophilic granulomatosis with polyangiitis, GPA = granulomatosis with polyangiitis, GPS = Goodpasture syndrome, HS = healthy subjects, INF = infectious diseases, MPA = microscopic polyangiitis, RPGN = rapidly progressive glomerulonephritis, SLE = systemic lupus erythematosus.
Table 3
Prevalence of ANCA by IIF, PR3-ANCA, MPO-ANCA, anti-GBM, and anti-dsDNA autoantibodies by CytoBead RPGN, classical testing employing ELISA and IIF on ethanol and formalin-fixed neutrophils, in 287 patients and controls. 
Discussion
A patient with RPGN suffering from selective or combined kidney and lung disease is classified as clinical emergency case and has to be treated very fast to avoid fatal progression of disease. In particular, patients with GPS are identified to have the worst prognosis of all RPGN patients without the correct medical treatment. [2] As a matter of fact, in such critical settings, autoAb analysis is crucial for diagnosing patients adequately. Thus, determination of anti-GBM autoAbs for GPS, ANCA for ANCAassociated RPGN, and autoAb to dsDNA are recommended for an appropriate serological diagnosis of RPGN. [34, [41] [42] [43] [44] [45] However, the analysis of all these parameters requires different techniques and is time consuming. Hence, there is a need for 1 step multiplex analysis addressing the urgent need for express RPGN serology.
In this context, the present study evaluated the multiparametric assay CytoBead RPGN for the simultaneous analysis of ANCA on ethN, MPO-ANCA, PR3-ANCA, and autoAbs to GBM and dsDNA.
With regard to ANCA pattern interpretation, the majority of patterns interpreted by AKLIDES were in line with the findings of a human expert. The AKLIDES system gives the result "unrecognized," when the pattern is not a classical cytoplasmic, perinuclear, or nuclear one, thus further interpretation by an expert is possible using the saved TIF images afterwards. [30, 46] In that case, the "unrecognized" pattern could be declared as atypical or classified as perinuclear, cytoplasmic, or nuclear. The very good concordance of automated and manually obtained fluorescence patterns in this study might provide the basis for a Table 4 Comparison of ANCA by IIF, PR3-ANCA, MPO-ANCA, anti-GBM, and anti-dsDNA autoantibody (autoAb) analysis by CytoBead RPGN and classical testing employing ELISA in 287 patients and controls. ANCA = anti-neutrophil cytoplasmic antibody, CI = confidence interval, ELISA = enzyme-linked immunosorbent assays, GBM = glomerular basement membrane, IIF = indirect immunofluorescence, MPO = myeloperoxidase, PR3 = proteinase 3, RPGN = rapidly progressive glomerulonephritis. Table 5 Comparison of automated and manual ANCA pattern evaluation by the AKLIDES system and an expert in ANCA diagnostics. successful introduction of automated ANCA reading into routine diagnostics of RPGN and AAV. The present data are corroborated by recent reports demonstrating the usefulness of the novel pattern recognition algorithms used by the automated interpretation system AKLIDES for ANCA reading. [30, 46] Digital fluorescence enables standardization and quantitative end-point titer reading for autoAb testing for the first time in autoimmune diagnostics and, thus, offers new exciting perspectives with regard to automation and multiplexing. [36] [37] [38] [39] For rapid simultaneous multiparametric quantitative determination of several specific RPGN-specific autoAbs, antigen-coated fluorescent microbeads, and lot-specific calibration curves fitted by asymmetric 5-parameter equations were employed. [28] [29] [30] Of note, obtained diagnostic parameters for MPO-ANCA, PR3-ANCA, anti-GBM, and anti-dsDNA autoAbs in MPA, GPA, GPS, and SLE matched literature data adequately (Table 6) . [41, 42, 45, [47] [48] [49] [50] In fact, anti-dsDNA antibody detection by CytoBead RPGN showed a diagnostic sensitivity of 83.3% with a diagnostic specificity of 97.3% in patients with SLE compared to a routine ELISA used by default in the nephrology department demonstrating 85.7% diagnostic sensitivity along with a poorer diagnostic specificity of only 84.8%. [47] Indeed, comparative anti-dsDNA autoAb analysis revealed a significant difference for both techniques and a fair agreement only. As a fact, CytoBead RPGN determined significantly less false-positive anti-dsDNA autoAb findings compared to ELISA.
The better specificity of the CytoBead RPGN anti-dsDNA autoAb detection might be a result of the specific covalent coupling strategy of the complete and nonfragmented dsDNA molecules to the activated microbead surface. [6] In addition, the agreement of anti-GBM autoAb, PR3-ANCA, and MPO-ANCA testing by CytoBead RPGN with classical corresponding ELISA was very good.
These findings support the assumption that the CytoBead RPGN is an attractive alternative to classical single testing regarding the analysis of all diagnostic relevant antibody specificities for the correct serological diagnosis of RPGN variants.
Furthermore, CytoBead RPGN is characterized by a very low incubation time of 1 h in contrast to current single routine tests. Hence, treatment of RPGN patients could start much earlier by addressing the most critical limiting factor for patients well-being or even survival.
Another characteristic of the CytoBead RPGN assay is its flexibility with regard to the autoimmune laboratory. Indeed, the assay can be run manually and interpreted by a conventional fluorescent microscope for qualitative autoAb assessment. Thus, emergency diagnostics for RPGN can be run without the need of expensive equipment by retaining all the benefits of multiplex autoAb analysis.
Our study has certain limitations. HS are not age and gender matched with the study cohorts. Further, the relevant prevalences of the disease cohorts do probably not reflect the actual prevalences in most nephrology departments. In order to obtain quantitative data for further evaluation, an automated interpretation system would have been necessary.
Conclusions
The multiparametric CytoBead technology is a unique combination of screening and confirmatory autoAb testing for RPGN serology and might be a very promising alternative to classical time-consuming single parameter testing. In the present study, CytoBead RPGN demonstrated satisfactory assay performance of the multiplex reaction environment for the detection of ANCA, PR3-ANCA, MPO-ANCA, autoAb to dsDNA and GBM addressing the need for emergency testing in routine autoimmune laboratories. Table 6 Comparison of diagnostic performance parameters of autoantibodies detected by CytoBead RPGN in patients with GPA, MPA, anti-GBM nephritis/GPS, and SLE. PR3-ANCA, MPO-ANCA, autoAb to anti-GBM, and anti-dsDNA were determined by CytoBead RPGN. Disease prevalence reflects the prevalence of the given disease in the whole study cohort. ÀLR = negative likelihood ratio, +LR = positive likelihood ratio, ANCA = anti-neutrophil cytoplasmic antibody, CI = confidence interval, GBM = glomerular basement membrane, GPA = granulomatosis with polyangiitis, GPS = Goodpasture syndrome, MPA = microscopic polyangiitis, MPO = myeloperoxidase, NPV = negative predictive value, PPV = positive predictive value, PR3 = proteinase 3, RPGN = rapidly progressive glomerulonephritis, SLE = systemic lupus erythematosus.
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